Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 May;94(1):27–36. doi: 10.1111/j.1476-5381.1988.tb11496.x

Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig.

V Lagente 1, S Desquand 1, P Hadvary 1, M Cirino 1, A Lellouch-Tubiana 1, J Lefort 1, B B Vargaftig 1
PMCID: PMC1853911  PMID: 3401641

Abstract

1. In vitro, Ro 19-3704, a structurally related antagonist of platelet-activating factor (Paf) inhibited selectively rabbit platelet aggregation. In vivo, administered intravenously, it inhibited bronchoconstriction, leukopenia, thrombocytopenia and the accompanying accumulation of platelet aggregates in guinea-pig lung microvessels induced by i.v. Paf. Administered by aerosol, Ro 19-3704 failed to inhibit bronchoconstriction, thrombocytopenia or leukopenia due to i.v. Paf. 2. Bronchoconstriction induced by Paf, in aerosol form, was blocked by Ro 19-3704 administered by the i.v. or aerosol route, which suggests that it interacts with pulmonary cells responsible for bronchoconstriction. 3. Ro 19-3704 has free radical scavenging properties, since it inhibited the production of superoxide anions by macrophages stimulated by Paf and by N-formyl-methionyl-leucyl-phenylalanine (FMLP). Ro 18-7715, another Paf antagonist and analogue of Ro 19-3704, failed to inhibit the production of superoxide anions by macrophages stimulated by FMLP at concentrations which were effective against Paf. 4. Administered intravenously, Ro 19-3704 failed to block bronchoconstriction induced by an i.v. injection of ovalbumin to guinea-pigs passively sensitized with anti-ovalbumin antiserum. Passive pulmonary anaphylaxis due to an aerosol of ovalbumin was blocked by i.v. Ro 19-3704.

Full text

PDF
27

Images in this article

34Figure 10
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson P., Bergstrand H. Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: effect of long-term treatment with sodium cromoglycate and aminophylline. Br J Pharmacol. 1981 Nov;74(3):601–609. doi: 10.1111/j.1476-5381.1981.tb10470.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cirino M., Lagente V., Lefort J., Vargaftig B. B. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. Prostaglandins. 1986 Jul;32(1):121–126. doi: 10.1016/0090-6980(86)90153-x. [DOI] [PubMed] [Google Scholar]
  3. Desquand S., Touvay C., Randon J., Lagente V., Vilain B., Maridonneau-Parini I., Etienne A., Lefort J., Braquet P., Vargaftig B. B. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Eur J Pharmacol. 1986 Aug 7;127(1-2):83–95. doi: 10.1016/0014-2999(86)90208-6. [DOI] [PubMed] [Google Scholar]
  4. Detsouli A., Lefort J., Vargaftig B. B. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. Br J Pharmacol. 1985 Apr;84(4):801–810. doi: 10.1111/j.1476-5381.1985.tb17374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garcez Do Carmo L., Cordeiro R., Lagente V., Lefort J., Randon J., Vargaftig B. B. Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig. Int J Immunopharmacol. 1986;8(8):985–995. doi: 10.1016/0192-0561(86)90101-3. [DOI] [PubMed] [Google Scholar]
  6. Handley D. A., Van Valen R. G., Saunders R. N. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. Immunopharmacology. 1986 Jun;11(3):175–182. doi: 10.1016/0162-3109(86)90019-6. [DOI] [PubMed] [Google Scholar]
  7. LUFT J. H. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961 Feb;9:409–414. doi: 10.1083/jcb.9.2.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lagente V., Touvay C., Randon J., Desquand S., Cirino M., Vilain B., Lefort J., Braquet P., Vargaftig B. B. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Prostaglandins. 1987 Feb;33(2):265–274. doi: 10.1016/0090-6980(87)90011-6. [DOI] [PubMed] [Google Scholar]
  9. Lefort J., Rotilio D., Vargaftig B. B. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Br J Pharmacol. 1984 Jul;82(3):565–575. doi: 10.1111/j.1476-5381.1984.tb10795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lefort J., Vargaftig B. B. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid. Br J Pharmacol. 1978 May;63(1):35–42. doi: 10.1111/j.1476-5381.1978.tb07771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lellouch-Tubiana A., Lefort J., Pirotzky E., Vargaftig B. B., Pfister A. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. Br J Exp Pathol. 1985 Jun;66(3):345–355. [PMC free article] [PubMed] [Google Scholar]
  12. MASSEY V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta. 1959 Jul;34:255–256. doi: 10.1016/0006-3002(59)90259-8. [DOI] [PubMed] [Google Scholar]
  13. Maridonneau-Parini I., Lagente V., Lefort J., Randon J., Russo-Marie F., Vargaftig B. B. Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. Biochem Biophys Res Commun. 1985 Aug 30;131(1):42–49. doi: 10.1016/0006-291x(85)91767-x. [DOI] [PubMed] [Google Scholar]
  14. Pretolani M., Lefort J., Malanchère E., Vargaftig B. B. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Eur J Pharmacol. 1987 Aug 21;140(3):311–321. doi: 10.1016/0014-2999(87)90288-3. [DOI] [PubMed] [Google Scholar]
  15. Terashita Z., Tsushima S., Yoshioka Y., Nomura H., Inada Y., Nishikawa K. CV-3988 - a specific antagonist of platelet activating factor (PAF). Life Sci. 1983 Apr 25;32(17):1975–1982. doi: 10.1016/0024-3205(83)90049-8. [DOI] [PubMed] [Google Scholar]
  16. Vargaftig B. B., Lefort J., Chignard M., Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980 Jul 25;65(2-3):185–192. doi: 10.1016/0014-2999(80)90391-x. [DOI] [PubMed] [Google Scholar]
  17. Vargaftig B. B., Lefort J., Wal F., Chignard M. Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction. Bull Eur Physiopathol Respir. 1981;17(4):723–736. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES